Nonresponse to Hepatitis B Vaccine
- 22 February 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (8) , 550-552
- https://doi.org/10.1056/nejm199002223220812
Abstract
Alper and colleagues were able to define genetic markers for a low antibody response to hepatitis B vaccine (Sept. 14 issue).1 Persons who had a low level of hepatitis B surface antibody (anti-HBs) after they had been vaccinated three times were homozygous for a specific extended haplotype of the major histocompatibility complex (MHC) — HLA-B8,BF*S,C2*C,C4A*Q0,C4B*1, DR3, in which Q0 denoted a null gene. In other words, these subjects were deficient in C4A, one of the two forms of human C4.Keywords
This publication has 16 references indexed in Scilit:
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- The role of interleukin 2 in autoimmunityImmunology Today, 1989
- Molecular heterogeneity of complement component c4‐null and 21‐hydroxylase genes in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Are MHC class II-restricted cytotoxic T lymphocytes important?Immunology Today, 1987
- LymphokinesNew England Journal of Medicine, 1987
- Deletion of C4A genes in patients with systemic lupus erythematosusArthritis & Rheumatism, 1987
- Complement‐mediated adherence of immune complexes to human erythrocytesFEBS Letters, 1987
- PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTESThe Lancet, 1984
- Defective Fc-Receptor Functions Associated with the HLA-B8/DRw3 HaplotypeNew England Journal of Medicine, 1981
- Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus ErythematosusNew England Journal of Medicine, 1979